Immune System Modulators
Immune System Modulators - Related Videos
09:10
siRNA Electroporation to Modulate Autophagy in Herpes Simplex Virus Type 1-Infected Monocyte-Derived Dendritic Cells
0 Views •
Cited by 5 •
2019
In this study, we present inhibitor- and siRNA-based strategies to interfere with autophagic flux in Herpes simplex virus type-1 (HSV-1)-infected monocyte-derived dendritic cells.
01:38
What is the Immune System?
0 Views •
2019
Overview The immune system comprises diverse biological structures and processes that protect the body from disease. These processes can be classified into innate and adaptive immunity. To work effectively, the immune system needs to detect pathogens by distinguishing the body’s own structures from foreign elements. If this determination fails, autoimmune diseases occur in which the immune system reacts against the body’s own tissue. The Innate Immune System Acts Fast and Non-specifically
10:08
Establishing a Three-Dimensional Coculture Module of Epithelial Cells Using Nanofibrous Membranes
0 Views •
2024
Here, we demonstrate how epithelial cells cultured with fibroblasts in the nanofibrous membrane-based two-layer system can stably adhere to and grow on the membrane.
05:07
Isolation, Characterization and Functional Examination of the Gingival Immune Cell Network
0 Views •
Cited by 30 •
2016
We have established a technique for the isolation, phenotypic characterization and functional analysis of immune cells from murine gingiva.
01:36
Humoral Immune Responses
0 Views •
2019
Overview The humoral immune response, also known as the antibody-mediated immune response, targets pathogens circulating in “humors,” or extracellular fluids, such as blood and lymph. Antibodies target invading pathogens for destruction via multiple defense mechanisms, including neutralization, opsonization, and activation of the complement system. Patients that are impaired in the production of antibodies suffer from severe and frequent infections by common pathogens and unusual pathogens. B...
FAQs
Their effects arise from changes in receptor signaling, cytokine production, immune-cell activation, or inhibitory checkpoint pathways. Altering these control points can change how strongly immune cells respond and how long that response persists. This makes the same broad defense system adaptable to different biological conditions, while also creating a need to control excessive or prolonged activation.
Cytokines help coordinate immune activity, so changing their production can influence the intensity and organization of a response. Modulating this signaling may strengthen coordinated defenses or reduce harmful inflammation, depending on the biological situation. Studying cytokine-related effects therefore helps researchers connect molecular changes with broader outcomes in infection, autoimmune disease, and inflammatory conditions.
Activation pathways promote immune-cell responses, whereas inhibitory checkpoints provide regulatory signals that limit or restrain those responses. Immune system modulators can influence either side of this balance. Examining the difference is important because increasing defensive activity may be useful in some settings, while strengthening inhibitory control may help reduce damaging overactivation in others.
Researchers can compare the strength, duration, and specificity of immune responses under different biological conditions. They may also examine whether changes involve receptor signaling, cytokine production, immune-cell activation, or inhibitory pathways. This framework links the modulator’s molecular action to the resulting immune behavior and supports evaluation of whether the response is appropriately targeted or excessively broad.
They are studied in contexts where immune activity must be enhanced, reduced, or redirected, including autoimmune disease, cancer, infection, inflammation, and transplant rejection. The relevant goal differs by condition: researchers may seek stronger coordinated defenses, reduced harmful activity, or more selective control. These applications show why mechanism-based evaluation is central to developing targeted approaches.
Researchers assess whether altering immune signaling produces an effective response without causing excessive activation. They consider the response’s strength, duration, and specificity, then relate those features to the biological condition under study. This balance is especially relevant when investigating targeted therapies, because useful immune control requires preserving protective defenses while limiting responses that damage tissues or disrupt biological function.